Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025459
Filing Date
2020-09-16
Accepted
2020-09-16 20:54:24
Documents
2
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7204
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4786
  Complete submission text file 0000899243-20-025459.txt   13316
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address
Stehman-Breen Catherine (Reporting) CIK: 0001702233 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39509 | Film No.: 201179951

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations